Luteal phase consequences of low-dose gonadotropin-releasing hormone agonist therapy in nonluteal-supported in vitro fertilization cycles**Supported in part by the Vicksburg Hospital Medical Foundation, Vicksburg, Mississippi.

Autor: Long, Cecil A., Sopelak, Victoria M., Lincoln, Stephen R., Cowan, Bryan D.
Zdroj: Fertility and Sterility; September 1995, Vol. 64 Issue: 3 p573-576, 4p
Abstrakt: To determine the follicular and luteal phase impact of low-dose GnRH agonist (GnRH-a) treatment during follicular stimulation for IVF.
Databáze: Supplemental Index